230 related articles for article (PubMed ID: 37820596)
1. Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire, and Hidradenitis Suppurativa Quality of Life Questionnaire.
Ingram JR; Ciaravino V; Rolleri R; Pansar I; Dias-Barbosa C; Kirby JS
Dermatology; 2024; 240(1):65-76. PubMed ID: 37820596
[TBL] [Abstract][Full Text] [Related]
2. Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.
Kimball AB; Sundaram M; Banderas B; Foley C; Shields AL
J Dermatolog Treat; 2018 Mar; 29(2):152-164. PubMed ID: 28608738
[TBL] [Abstract][Full Text] [Related]
3. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.
Kirby JS; Thorlacius L; Villumsen B; Ingram JR; Garg A; Christensen KB; Butt M; Esmann S; Tan J; Jemec GBE
Br J Dermatol; 2020 Aug; 183(2):340-348. PubMed ID: 31705538
[TBL] [Abstract][Full Text] [Related]
4. Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research.
Otten M; Augustin M; Blome C; Topp J; Niklaus M; Hilbring C; Bechara FG; Pinter A; Zouboulis CC; Anzengruber F; Kirsten N
Acta Derm Venereol; 2023 Jan; 103():adv00859. PubMed ID: 36129249
[TBL] [Abstract][Full Text] [Related]
5. Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.
Kirby JS; Hereford B; Thorlacius L; Villumsen B; Ingram JR; Garg A; Butt M; Esmann S; King T; Tan J; Jemec GBE
Br J Dermatol; 2021 Apr; 184(4):681-687. PubMed ID: 32602129
[TBL] [Abstract][Full Text] [Related]
6. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.
Thorlacius L; Esmann S; Miller I; Vinding G; Jemec GBE
Skin Appendage Disord; 2019 Jun; 5(4):221-229. PubMed ID: 31367600
[TBL] [Abstract][Full Text] [Related]
7. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
[TBL] [Abstract][Full Text] [Related]
8. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa.
Sisic M; Kirby JS; Boyal S; Plant L; McLellan C; Tan J
J Cutan Med Surg; 2017; 21(2):152-155. PubMed ID: 27837158
[TBL] [Abstract][Full Text] [Related]
9. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
[TBL] [Abstract][Full Text] [Related]
10. Convergent Validity of Suffering and Quality of Life as Measured by The Hidradenitis Suppurativa Quality of Life.
Kursawe Larsen C; Kjaersgaard Andersen R; Kirby JS; Tan J; Saunte DML; Jemec GBE
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):1577-1581. PubMed ID: 33539563
[TBL] [Abstract][Full Text] [Related]
11. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.
Kirby JS; Butt M; King T
Br J Dermatol; 2020 Apr; 182(4):940-948. PubMed ID: 31233623
[TBL] [Abstract][Full Text] [Related]
12. Development of a patient-reported outcome questionnaire to assess signs and symptoms of hidradenitis suppurativa: The Hidradenitis Suppurativa Symptom Diary.
Alavi A; Baradaran S; Mathias SD; Colwell HH; Song M; Hamzavi IH; Han C
J Am Acad Dermatol; 2023 May; 88(5):1123-1125. PubMed ID: 34808326
[No Abstract] [Full Text] [Related]
13. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
[TBL] [Abstract][Full Text] [Related]
14. Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study.
Raimondi G; Samela T; Fania L; Abeni D
Front Public Health; 2023; 11():1284365. PubMed ID: 38026379
[TBL] [Abstract][Full Text] [Related]
15. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
[TBL] [Abstract][Full Text] [Related]
16. The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.
Sampogna F; Fania L; Mazzanti C; Caggiati A; Pallotta S; Panebianco A; Mastroeni S; Didona B; Pintori G; Abeni D
Dermatology; 2019; 235(4):308-314. PubMed ID: 31121589
[TBL] [Abstract][Full Text] [Related]
17. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Three-Item Skindex-Mini Among Hidradenitis Suppurativa Patients With Diverse Racial Backgrounds.
Orenstein LAV; Amah A; Shaw FM; Zhang C; Swerlick RA; Chen SC
J Cutan Med Surg; 2020; 24(5):457-460. PubMed ID: 32469259
[TBL] [Abstract][Full Text] [Related]
19. Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa.
McLellan C; Sisic M; Oon HH; Tan J
J Cutan Med Surg; 2018; 22(2):142-146. PubMed ID: 28992738
[TBL] [Abstract][Full Text] [Related]
20. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
